-+ 0.00%
-+ 0.00%
-+ 0.00%

4D MOLECULAR THERAPEUTICS - FIRST PATIENTS ENROLLED IN 4SIGHT PHASE 3 TRIAL FOR 4D-150 IN DME

Reuters·09/28/2026 12:03:07